![]() ![]() Kullo's laboratory conducts clinical trials in genomic medicine, such as the recently concluded Myocardioal Infarction Genes (MI-GENES) study, which assessed the effect on LDL cholesterol of disclosing a genetic risk score for coronary heart disease based on 28 susceptibility variants. Implementing genomic medicine in the EHR.Kullo's laboratory is engaged in several projects related to FH, including the use of electronic phenotyping for rapid ascertainment of FH from electronic health records (EHRs), use of EHR-based strategies to improve outcomes in patients with FH, assigning pathogenicity to variants identified from sequencing of FH-related genes and investigating the pleiotropic effects of FH-related genes. Kullo's lab uses family history studies, linkage studies, candidate gene association studies, genome-wide association studies and genome sequencing to study the genetic basis of atherosclerosis. Genetics of arterial plaques (atherosclerosis).These include genetic markers, circulating biomarkers, and noninvasive tests of arterial function and structure. Kullo is investigating the use of new methodologies in refining cardiovascular risk stratification. Through his Atherosclerosis and Lipid Genomics Laboratory, Dr. Kullo, M.D., is in biomarkers of cardiovascular risk. Total Drug Medicare Standardized Payment Amount: $0.The main research interest of Iftikhar J.Total Drug Medicare Payment Amount: $0.00.Total Drug Medicare Allowed Amount: $0.00.Total Drug Submitted Charge Amount: $0.00.Number of Medicare Beneficiaries With Drug Services: 0.Number of HCPCS Associated With Drug Services: 0.Total Medical Medicare Standardized Payment Amount: $12,180.10.Total Medical Medicare Payment Amount: $11,171.93.Total Medical Medicare Allowed Amount: $14,490.37. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |